Gasless Single-port Laparoscopic-assisted Radical Resection for Rectal Carcinoma

NCT ID: NCT03318185

Last Updated: 2018-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-11-01

Study Completion Date

2020-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project aims to investigate the safety and effectiveness of gasless single-port laparoscopic-assisted radical resection (GSLR) in the treatment of rectal carcinoma.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The gasless single-port laparoscopic-assisted surgery (GSLS) is associated with rapid recovery and shorter postoperative hospital stay and no pneumoperitoneum complications occur after the operation. To our knowledge, there have been no reports about GSLS applied to the treatment of gastrointestinal cancer in the world. To explore the safety and effectiveness of GSLS in rectal cancer patients, this project plans to evaluate the operation time, cardio-pulmonary function, postoperative pain, immunologic function and restoration of bowel function after the operation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laparoscopic Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

gasless single-port laparoscopic surgery

radical resection of rectal carcinoma is performed by gasless single-port laparoscopic-assisted surgery.

Group Type EXPERIMENTAL

gasless single-port laparoscopic surgery

Intervention Type PROCEDURE

The single-port laparoscopic surgery is performed when the maneuvering room is provided by external suspension system.

conventional laparoscopic surgery

radical resection of rectal carcinoma is performed by conventional laparoscopic surgery.

Group Type SHAM_COMPARATOR

conventional laparoscopic surgery

Intervention Type PROCEDURE

The multi-port laparoscopic surgery is performed when the belly is inflated with carbon dioxide to provide maneuvering room.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

gasless single-port laparoscopic surgery

The single-port laparoscopic surgery is performed when the maneuvering room is provided by external suspension system.

Intervention Type PROCEDURE

conventional laparoscopic surgery

The multi-port laparoscopic surgery is performed when the belly is inflated with carbon dioxide to provide maneuvering room.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Rectal carcinoma;The distance between tumor and anal verge is 5-15cm; The primary tumor can radical resect.

Exclusion Criteria

* Neoadjuvant therapy;Surgical contraindication.
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Second Affiliated Hospital of Chongqing Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jijian Wang, phD

Role: STUDY_CHAIR

The Second Affiliated Hospital of Chongqing Medical University

Yaxu Wang, phD

Role: PRINCIPAL_INVESTIGATOR

The Second Affiliated Hospital of Chongqing Medical University

Yang Li, phD

Role: PRINCIPAL_INVESTIGATOR

The Second Affiliated Hospital of Chongqing Medical University

Daihua Zhu, phD

Role: PRINCIPAL_INVESTIGATOR

The Second Affiliated Hospital of Chongqing Medical University

Jianbo Zhang, phD

Role: PRINCIPAL_INVESTIGATOR

The Second Affiliated Hospital of Chongqing Medical University

Haitao Gu, phD

Role: PRINCIPAL_INVESTIGATOR

The Second Affiliated Hospital of Chongqing Medical University

Shiji Zhou, phD

Role: PRINCIPAL_INVESTIGATOR

The Second Affiliated Hospital of Chongqing Medical University

Zhiquan Xu, Bachelor

Role: PRINCIPAL_INVESTIGATOR

The Second Affiliated Hospital of Chongqing Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gastrointestinal Surgery Department of the Second Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jijian Wang, phD

Role: CONTACT

02363693511

Jianbo Zhang, phD

Role: CONTACT

02363693510

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jijian Wang, MD,phD

Role: primary

86-23-63693511

Jianbo Zhang, MD,phD

Role: backup

86-23-63693510

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017140

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.